1. Home
  2. SVM vs CAPR Comparison

SVM vs CAPR Comparison

Compare SVM & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVM
  • CAPR
  • Stock Information
  • Founded
  • SVM N/A
  • CAPR 2005
  • Country
  • SVM Canada
  • CAPR United States
  • Employees
  • SVM N/A
  • CAPR N/A
  • Industry
  • SVM Precious Metals
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SVM Basic Materials
  • CAPR Health Care
  • Exchange
  • SVM Nasdaq
  • CAPR Nasdaq
  • Market Cap
  • SVM 663.6M
  • CAPR 578.4M
  • IPO Year
  • SVM N/A
  • CAPR N/A
  • Fundamental
  • Price
  • SVM $3.08
  • CAPR $13.70
  • Analyst Decision
  • SVM Strong Buy
  • CAPR Strong Buy
  • Analyst Count
  • SVM 1
  • CAPR 7
  • Target Price
  • SVM $5.10
  • CAPR $39.29
  • AVG Volume (30 Days)
  • SVM 3.4M
  • CAPR 1.1M
  • Earning Date
  • SVM 02-11-2025
  • CAPR 02-27-2025
  • Dividend Yield
  • SVM 0.42%
  • CAPR N/A
  • EPS Growth
  • SVM 63.39
  • CAPR N/A
  • EPS
  • SVM 0.29
  • CAPR N/A
  • Revenue
  • SVM $241,357,000.00
  • CAPR $23,228,045.00
  • Revenue This Year
  • SVM $33.21
  • CAPR N/A
  • Revenue Next Year
  • SVM $8.11
  • CAPR $74.85
  • P/E Ratio
  • SVM $12.04
  • CAPR N/A
  • Revenue Growth
  • SVM 16.71
  • CAPR 65.33
  • 52 Week Low
  • SVM $2.22
  • CAPR $3.52
  • 52 Week High
  • SVM $5.32
  • CAPR $23.40
  • Technical
  • Relative Strength Index (RSI)
  • SVM 46.62
  • CAPR 45.79
  • Support Level
  • SVM $2.92
  • CAPR $12.31
  • Resistance Level
  • SVM $3.27
  • CAPR $16.17
  • Average True Range (ATR)
  • SVM 0.14
  • CAPR 0.83
  • MACD
  • SVM 0.04
  • CAPR 0.07
  • Stochastic Oscillator
  • SVM 51.28
  • CAPR 36.01

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.

Share on Social Networks: